HC Wainwright reaffirmed their neutral rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 2024 earnings at $0.06 EPS, Q3 2024 earnings at ($0.28) EPS, Q4 2024 earnings at ($0.28) EPS, FY2024 earnings […]
Cincinnati Insurance Co. acquired a new stake in shares of The Oncology Institute, Inc. (NASDAQ:TOI – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 699,500 shares of the company’s stock, valued at approximately $1,427,000. A number of other institutional investors have […]
Fielder Capital Group LLC acquired a new position in shares of The Oncology Institute, Inc. (NASDAQ:TOI – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 70,192 shares of the company’s stock, valued at approximately $143,000. Fielder Capital Group LLC owned approximately […]
Fielder Capital Group LLC bought a new position in The Oncology Institute, Inc. (NASDAQ:TOI – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 70,192 shares of the company’s stock, valued at approximately $143,000. Several other hedge funds and other institutional investors also […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned a consensus recommendation of “Hold” from the three research firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 12-month price objective among brokerages that have updated their coverage on the stock in […]